The Era of Big Data and its Implication for Big Pharma: The integration of technology into health care has resulted in an abundance of data about our health. In this piece for the Health Affairs Blog, Marc Berger et al. discuss how “big [...] Read more
Research Ethics Roundup: Legal status of chimpanzees, paper microscopes, and more
Tags:As the April showers turn to May flowers, take a moment to check out some of the research ethics and oversight news that has been making headlines this month.
by Julie Fine, BS, Legal Specialist, Worldwide Research and Development, Pfizer, Inc., La Jolla, California
PRIM&R is pleased to introduce another member of the PRIM&R Blog Squad for the 2013 Advancing Ethical Research (AER) Conference. The Blog Squad is composed of PRIM&R members who will blog on Ampersand about the conference to [...] Read more
by Joan Rachlin, JD, MPH, Executive Director
Among the many topics that will be presented and discussed at the 2013 Advancing Ethical Research Conference is the ubiquitous issue of data transparency. Some of the most hotly debated questions making the research ethics rounds include who should interpret, distribute, review, and receive data, and with good reason. From WikiLeaks to National Security Agency (NSA) whistleblowers, and all other manner and [...] Read more
by Julie Fine, BS, legal specialist, Legal Division, Worldwide Research and Development, Pfizer Inc. (Please note: The views presented here are my own and do not reflect the positions or policies of Pfizer, Inc.)
During lunch on Tuesday, I took advantage of the opportunity to join other conference attendees for an intimate and informal question and answer session with Keynote Speaker, Read more